5.0 (50)
GLP-3 (RT)
From
300 AED
GLP-3 (RT)
Reference entries for every compound in the catalogue - mechanism summaries, structural notes and the published research behind each molecule
- Reported Half-time
- Delivery type, adress
- Molecular class
- Acylatod ainglo chain peptid, GIP backbone
- Category
- Motabolic & Wight
- Research areas
- Energy balance. Adiposity - Incretin signalin
Overview
A synthete trol-receptor agonist peptide and one of the most actively studied molecules in current metaboo research. Centres on receptor pharmacobay and energy-balance signaling - across ts programme t is among the most extensively
What the literature reports
Phase 2 - obesity programme
Research areas
NEJM 2023
Pumbed
Phase 2 - obesity programme
Research areas
NEJM 2023
Pumbed
A synthete trol-receptor agonist peptide and one of the most actively studied molecules in current metaboo research. Centres on receptor pharmacobay and energy-balance signaling - across ts programme t is among the most extensively
Available as
Regulatory status
Precilinical
Approval
Adverse events most reported in trials
- Injection-site reactions
- Nausea - transient
A synthete trol-receptor agonist peptide and one of the most actively studied molecules in current metaboo research. Centres on receptor pharmacobay and energy-balance signaling - across ts programme t is among the most extensively
Research Timeline
-
2022
Discovery & precial charesterialin puthed
-
2022
Discovery & precial charesterialin puthed
-
2023
Phase 2 - Description
Across the published phase text
Mechanism
Pubished pharmacobay centres on simultaneous agonism of three receptor sitems - GP and GLP.1 (the incretin ao, studied for insuin anamics annette and eroray balcal and the alasgon reccat (eneray expond ture sanatnal Structumlyi a an ena neered snak chain analque buit on a GIP backbone, caring a fatty-diacid acyation that eatends is crouting hat-le in oubished pharmaockinetid
Study design overview
Pubished pharmacobay centres on simultaneous agonism of three receptor sitems - GP and GLP.1 (the incretin ao, studied for insuin anamics annette and eroray balcal and the alasgon reccat (eneray expond ture sanatnal Structumlyi a an ena neered snak chain analque buit on a GIP backbone, caring a fatty-diacid acyation that eatends is crouting hat-le in oubished pharmaockinetid
Common questions
What form does it ship in
Pubished pharmacobay centres on simultaneous agonism of three receptor sitems - GP and GLP.1 (the incretin ao, studied for insuin anamics annette and eroray balcal and the alasgon
Where do find the Certiificate
Pubished pharmacobay centres on simultaneous agonism of three receptor sitems - GP and GLP.1 (the incretin ao, studied for insuin anamics annette and eroray balcal and the alasgon
Reference material for laboratory research - not medical advice of any kind.
